CNS Changes Following Upper Limb Loss

Recruiting Observational Study
Amputation, Congenital Upper Limb; Amelia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
70 (estimated)
Sponsor
University of Zurich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The objective of this study is to better understand the structural and functional changes that the central nervous system (CNS) undergoes following congenital upper limb loss. The focus is on the brain's sensory processing and how neuronal changes may relate to clinical measures. By doing so, the hope is to gain insight into the contribution of critical periods to the plasticity of the sensorimoto…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria - Patients: * Age 18-75 * Upper-limb congenital amputees with complete absence of a hand * Signed informed consent Exclusion Criteria - Patients: * Contraindications to magnetic resonance imaging * Neurological impairment of body function impairments not induced by spinal cord …
Contacts

Paige Howell, PhD

+41 44 632 32 94

paige.howell@hest.ethz.ch

CONTACT

Sanne Kikkert

+41 44 632 32 94

sanne.kikkert@balgrist.ch

CONTACT